Maryam Bozorgi
Overview
Explore the profile of Maryam Bozorgi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khanmirzaei A, Bozorgi M, Azarinoush G, Aghaei F, Bigdeli A, Jazi K, et al.
Mod Rheumatol Case Rep
. 2025 Jan;
PMID: 39829326
Diffuse Alveolar Hemorrhage (DAH) is an uncommon and potentially life-threatening occurrence in systemic lupus erythematous (SLE), involving bleeding into the alveolar space caused by the disruption of the alveolar-capillary basement...
2.
Masoumi M, Bozorgi M, Nourmohammadi Z, Mousavi M, Shariati A, Karami J
BMC Rheumatol
. 2024 Dec;
8(1):75.
PMID: 39722051
Background: Reducing inflammation is central to the management of RA. However, commonly used markers such as CRP and ESR, along with the DAS-28 score, have shown limitations. Hematologic indices, such...
3.
Habibi M, Ahmadvand M, Delbari P, Sabet S, Zare A, Mirjani M, et al.
Neuroradiol J
. 2024 Nov;
:19714009241303083.
PMID: 39604086
Background: The pRESET stent retriever is a self-expanding nitinol stent designed for mechanical thrombectomy in cases of large vessel occlusion during acute ischemic stroke. This systematic review and meta-analysis synthesize...
4.
Khazaei M, Bozorgi M, Rezakhani L, Bozorgi A
Int J Biol Macromol
. 2024 Oct;
281(Pt 2):136340.
PMID: 39374728
Novel biomaterials are necessary to fabricate biomimetic scaffolds for bone tissue engineering. In the present experiment, we aimed to fabricate and evaluate the osteogenic properties of nanohydroxyapatite/chitosan/decellularized placenta (nHA.Cs.dPL) composite...
5.
Bozorgi A, Khazaei M, Bozorgi M, Khazaei M
Cell Biochem Funct
. 2024 May;
42(4):e4038.
PMID: 38736214
The generation of insulin-producing cells (IPCs) is an attractive approach for replacing damaged β cells in diabetic patients. In the present work, we introduced a hybrid platform of decellularized amniotic...
6.
Khazaei M, Bozorgi M, Khazaei M, Aftabi M, Bozorgi A
Cell J
. 2024 Mar;
26(2):112-120.
PMID: 38459728
Objective: The aim of this study was to synthesize chitosan nanoparticles (Cs NPs) for resveratrol (RSV) delivery and assess their effectiveness in inducing autophagy in MDA-MB 231 cells. Materials And...
7.
Khazaei M, Bozorgi M, Khazaei M, Moradi A, Bozorgi A
Mol Biol Rep
. 2024 Mar;
51(1):388.
PMID: 38446390
Background: In the present experiment, we evaluated the impact of thymoquinone (TQ) and paclitaxel (PTX) treatment on MDA-MB-231 cell line growth inhibition via controlling apoptosis/autophagy. Materials And Results: MDA-MB-231cells were...
8.
Bozorgi A, Khazaei M, Bozorgi M, Sabouri L, Soleimani M, Jamalpoor Z
J Biomed Mater Res B Appl Biomater
. 2024 Jan;
112(1):e35362.
PMID: 38247246
Bifunctional tissue engineering constructs promoting osteogenesis and angiogenesis are essential for bone regeneration. Metal ion-incorporated scaffolds and fibrin encapsulation attract much attention due to low cost, nontoxicity, and tunable control...
9.
Bozorgi A, Haghighi Z, Khazaei M, Bozorgi M, Khazaei M
IET Nanobiotechnol
. 2022 Nov;
17(2):91-102.
PMID: 36420812
Herein, the authors synthesised chitosan nanoparticles (Cs NPs) as a resveratrol (RSV) carrier and evaluated their efficacy in stimulating apoptosis in MDA-MB 231 cells. Blank (Cs NPs) and RSV- Cs...
10.
Bozorgi A, Bozorgi M, Khazaei M
Cell Oncol (Dordr)
. 2022 Aug;
45(5):755-777.
PMID: 35943716
Background: Breast cancer (BC) is a highly prevalent solid cancer with a high-rise infiltration of immune cells, turning it into a significant candidate for tumor-specific immunotherapies. Chimeric antigen receptor (CAR)-T...